LncRNA CASC9 facilitates papillary thyroid cancer development and doxorubicin resistance via miR-28-3p/BCL-2 axis and PI3K/AKT signaling pathway
CASC9, as an oncogenic lncRNA, has a promotional effect on Dox resistance and PTC progression via miR-28-3p/BCL-2 axis and PI3K/AKT signaling pathway.
Authors
- Yun Peng (ORCID: https://orcid.org/0000-0001-8213-9716)
- Yuzhong Wen
- Chunhui He (ORCID: https://orcid.org/0000-0002-1068-9986)
- Jing Wang (ORCID: https://orcid.org/0000-0001-7199-4784)
- Jianping Yu
Institutions
- Ganzhou People's Hospital (CN)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1186/s13019-024-03129-4
- Citations
- 5
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 1.43